Gastrointestinal Conditions News

Nearly 600 cholera cases and more than 20 deaths have been reported in South Sudan, according to WHO.

Pentavalent rotavirus vaccine was well tolerated among infants in the neonatal ICU, with most post-vaccination symptoms attributed to preexisting symptoms, according to study findings in Pediatrics.

A seroprotective response to a challenge dose of hepatitis B vaccine was seen in more than 90% of study participants who received the vaccine an infant, according to recent study findings published in Pediatrics.

Using online restaurant reviews helped the New York City Department of Health and Mental Hygiene identify three previously unreported outbreaks related to the restaurants, according to a report in MMWR.

Approximately 1.8 million pounds of ground beef products produced by Wolverine Packing Co. in Detroit are being recalled due to possible contamination with Escherichia coli O157:H7, according to the US Department of Agriculture’s Food Safety and Inspection Service.

Children and teenagers with inflammatory bowel disease did not exhibit greater rates of clinical depression than those who do not have the disease, according to recent study data.

VANCOUVER, British Columbia — Preterm infants in the neonatal ICU reap more benefits from maternal breast milk than pasteurized human milk or infant formula, according to data presented at the 2014 Pediatric Academic Societies Annual Meeting.

BETHESDA, Md. — Children with rotavirus develop more severe gastroenteritis symptoms and are more likely to experience fever, dehydration and hospitalization than children with norovirus, according to data presented at the 2014 Annual Conference on Vaccine Research.

BETHESDA, Md. — Children with rotavirus develop more severe gastroenteritis symptoms and are more likely to experience fever, dehydration and hospitalization than children with norovirus, according to data presented at the 2014 Annual Conference on Vaccine Research.

Researchers at Cedars Sinai Pediatric IBD Center in Los Angeles conducted a retrospective 10-year review of 188 patients (aged 21 years or younger; 51.6% female) with inflammatory bowel disease (IBD). For study inclusion, all patients had to have received at least one dose of infliximab (IFX) and at least 1 year of follow-up.